$MTAC News
Last published 3y ago
- 3y agoMTACTLSITriSalus Life Sciences Completes Merger with MedTech Acquisition CorporationBusiness WireAdvances TriSalus' Platform Focused on Improving Outcomes for Patients with Liver and Pancreatic Cancer Expected to Advance Technology Development and Sales Growth Advancing SD-101 Into Phase 2 Clinical Trial in
- 3y agoMTACMedTech Acquisition Corporation Adjourns Special Meeting of StockholdersBusiness WireMedTech Acquisition Corporation (NASDAQ:MTAC) ("MedTech" or the "Company") today announced that it convened and then adjourned, without conducting any business, its special meeting of stockholders (the "Special
- 3y agoMTACTriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual MeetingBusiness WireNew data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels TriSalus Life Sciences® Inc., (TriSalus
- 3y agoMTACTriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver MetastasesBusiness WireTriSalus Life Sciences® Inc., ("TriSalus" or the "Company"), an oncology company in the process of going public through a business combination transaction (the "Business Combination") with MedTech Acquisition
- 3y agoMTACTriSalus Life Sciences Appoints James Alecxih to Lead Device Technology BusinessBusiness WireTriSalus Life Sciences®, Inc. ("TriSalus" or the "Company"), an oncology company in the process of going public through a business combination transaction (the "Business Combination") with MedTech Acquisition
- 3y agoMTACTriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology™-01 and -02 StudiesBusiness WireData Further Supports the Potential of the Company's Therapeutic Platform to Improve Immunotherapy Outcomes for Patients with Liver and Pancreatic Tumors TriSalus Life Sciences®, Inc. ("TriSalus" or the
- 3y agoMTACTriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) Clinical Trial Progress and Pre-clinical Research DevelopmentsBusiness WireTriSalus Life Sciences®, Inc. ("TriSalus" or the "company"), an oncology company in the process of going public through a business combination transaction (the "Business Combination") with MedTech Acquisition
- 3y agoMTACMTACUMTACWMedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of StockholdersGlobeNewswireThe Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (NASDAQ:MTAC)
- 3y agoMTACTriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical StudiesBusiness WireTriSalus Life Sciences®, Inc. ("TriSalus") (the "Company"), an oncology therapeutics company in the process of going public through a business combination transaction (the "Business Combination") with MedTech
- 3y agoMTACTriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition CorporationBusiness WireOncology Therapeutics Company Focused on Transforming Cancer Treatment with Proprietary Innovative Therapies and Disruptive Delivery Technology Company Has a Differentiated and Fast-growing, Commercial Drug Delivery
- 4y agoMTACMedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business CombinationGlobeNewswireTEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (NASDAQ:MTAC) ("MedTech"), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, and Memic Innovative S
- 4y agoMTACMemic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021PR NewswireTEL AVIV, Israel and FORT LAUDERDALE, Fla., Jan. 6, 2022 /PRNewswire/ -- Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that HCA Florida
- 5y agoMTACMemic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition CorporationPR NewswireTEL AVIV, Israel and FORT LAUDERDALE, Fla., Sept. 9, 2021 /PRNewswire/ -- Memic Innovative Surgery Ltd. (the "Company" or "Memic"), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announ
- 5y agoADFFRSGMTACSLCRMoore Kuehn Encourages FRSG, MTAC, SLCR, and ADF Investors to Contact Law FirmGlobeNewswireNEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair
- 5y agoMTACMTACUPeregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC dealPR NewswireOR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acquisition Corporation (NASDAQ:MTAC), a publicly traded
- 5y agoMTACMemic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business CombinationPR NewswireTEL AVIV, Israel and FORT LAUDERDALE, Fla., Aug. 13, 2021 /PRNewswire/ -- Memic Innovative Surgery Ltd. (the "Company" or "Memic"), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, and MedTech
- 5y agoMTACMTACUMedTech Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QGlobeNewswireNew York, NY, June 02, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (NASDAQ:MTACU) (the "Company") today announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as
- 5y agoMTACMedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021GlobeNewswireNew York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq:MTACU) (the “Company”) announced today that, commencing February 8, 2021, holders of the 25,000,000 units sold...
- 5y agoMTACMedTech Acquisition Corporation Announces Closing of Upsized $250,000,000 Initial Public OfferingGlobeNewswireNew York, NY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it closed its initial public offering of 25,000,000 units, which included...
- 5y agoMTACMedTech Acquisition Corporation Announces Pricing of Upsized $220,000,000 Initial Public OfferingGlobeNewswireNew York, NY, Dec. 17, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it priced its upsized initial public offering of 22,000,000 units at $10.00 per...